CRDF Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 7.80%

Insider Buying (Last 12 Months): $41,100.00

Insider Selling (Last 12 Months): $0.00

Cardiff Oncology Insider Trading History Chart

Cardiff Oncology Share Price & Price History

^$2.50

▼ -0.03 (-1.19%)

As of 11/21/2024 06:41 PM ET

Days: 30 | 90 | 365

JD Vance Predicts: Wall Street vs. Trump & Your Money

From Priority Gold | Ad

Trump's back in the White House, but Wall Street is pissed. Here's the deal: Wall Street's about to purposely crash the bond market to sabotage Trump's comeback.

Get your free guide NOW before it's too late.

Cardiff Oncology Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
12/19/2023	Gary W. Pace	Director	Buy	30,000	$1.37	$41,100.00	697,761
11/25/2022	Mark Erlander	CEO	Buy	10,000	$1.43	$14,300.00	24,481
9/19/2022	Lale White	Director	Buy	15,000	$1.64	$24,600.00	113,788
9/16/2022	James E. Levine	CFO	Buy	30,000	$1.56	$46,800.00	60,000
9/15/2022	Renee P Tannenbaum	Director	Buy	10,000	$1.72	$17,200.00	10,000

Download Our Tesla Ebook For Free

From DTI | Ad

Like many of you, we here at the TradingPub are bullish on Tesla long term. We believe the company will continue to be a leader in technology, EVs and A.I. We also believe it’s share price will be rewarded in a big way… In fact, our #1 Tesla expert just published a brand new Ebook regarding Tesla’s future, and we’d like to send it to you at no cost.

To claim your copy free of charge simply follow this link.

SEC Filings (Institutional Ownership Changes) for Cardiff Oncology (NASDAQ:CRDF)

16.29% of Cardiff Oncology stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Cardiff Oncology Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
11/19/2024	Barclays PLC	53,089	$0.14M	0.0%	+291.9%	0.104%
11/19/2024	Invst LLC	22,500	$60K	0.0%	-37.5%	0.044%
11/16/2024	Geode Capital Management LLC	928,232	$2.48M	0.0%	+1.9%	1.815%
11/15/2024	Barclays PLC	53,089	$0.14M	0.0%	+291.9%	0.104%
11/15/2024	XTX Topco Ltd	120,384	$0.32M	0.0%	+44.3%	0.235%
11/15/2024	Jane Street Group LLC	43,998	$0.12M	0.0%	-59.1%	0.086%
11/15/2024	State Street Corp	832,652	$2.22M	0.0%	+3.4%	1.628%
11/12/2024	Charles Schwab Investment Management Inc.	121,293	$0.32M	0.0%	+11.5%	0.261%
11/7/2024	MAI Capital Management	663,363	$1.77M	0.0%	+0.7%	1.425%
11/5/2024	GSA Capital Partners LLP	186,650	$0.50M	0.0%	+432.7%	0.401%
10/23/2024	Assenagon Asset Management S.A.	270,523	$0.72M	0.0%	-77.8%	0.605%
10/3/2024	SG Americas Securities LLC	23,937	$64K	0.0%	N/A	0.054%
9/16/2024	Point72 DIFC Ltd	12,284	$27K	0.0%	N/A	0.026%
9/16/2024	Cubist Systematic Strategies LLC	68,730	$0.15M	0.0%	+112.9%	0.148%
8/16/2024	Invst LLC	36,000	$74K	0.0%	N/A	0.077%
8/14/2024	Cubist Systematic Strategies LLC	68,730	$0.15M	0.0%	+112.9%	0.154%
8/14/2024	Point72 DIFC Ltd	12,284	$27K	0.0%	N/A	0.027%
8/14/2024	Marshall Wace LLP	298,829	$0.66M	0.0%	-31.2%	0.668%
8/12/2024	XTX Topco Ltd	83,437	$0.19M	0.0%	N/A	0.187%
8/12/2024	Blair William & Co. IL	227,630	$0.51M	0.0%	+32.2%	0.489%
8/9/2024	Renaissance Technologies LLC	157,490	$0.35M	0.0%	+82.9%	0.352%
8/9/2024	Dimensional Fund Advisors LP	19,098	$42K	0.0%	+34.4%	0.043%
8/8/2024	Thoroughbred Financial Services LLC	52,375	$0.12M	0.0%	N/A	0.117%
8/8/2024	American Century Companies Inc.	45,360	$0.10M	0.0%	+98.7%	0.101%
8/8/2024	Ground Swell Capital LLC	17,098	$38K	0.0%	N/A	0.038%
8/1/2024	Rhumbline Advisers	45,993	$0.10M	0.0%	N/A	0.103%
7/26/2024	Bank of New York Mellon Corp	115,304	$0.26M	0.0%	N/A	0.258%
7/18/2024	Assenagon Asset Management S.A.	1,215,922	$2.70M	0.0%	+380.6%	2.719%
5/16/2024	Elkhorn Partners Limited Partnership	39,000	$0.21M	0.1%	-40.5%	0.087%
5/10/2024	Vanguard Group Inc.	1,921,257	$10.26M	0.0%	+0.5%	4.296%
5/9/2024	Blair William & Co. IL	172,180	$0.92M	0.0%	+32.4%	0.385%
5/3/2024	Callan Capital LLC	42,747	$0.23M	0.0%	+37.2%	0.096%
4/24/2024	Assenagon Asset Management S.A.	252,982	$1.35M	0.0%	N/A	0.566%
4/22/2024	PFG Investments LLC	10,001	$53K	0.0%	N/A	0.022%
11/6/2023	Callan Capital LLC	31,147	$43K	0.0%	+129.2%	0.070%
11/6/2023	Assenagon Asset Management S.A.	84,272	$0.12M	0.0%	-40.8%	0.189%
7/25/2023	Assenagon Asset Management S.A.	142,428	$0.21M	0.0%	-63.9%	0.319%
7/21/2023	Creative Planning	57,750	$85K	0.0%	+135.7%	0.129%
5/4/2023	Denver Wealth Management Inc.	18,235	$30K	0.0%	N/A	0.041%
4/18/2023	Assenagon Asset Management S.A.	394,994	$0.65M	0.0%	+120.0%	0.884%
2/13/2023	GSA Capital Partners LLP	352,186	$0.49M	0.1%	+198.8%	0.788%
2/10/2023	Blair William & Co. IL	151,575	$0.21M	0.0%	-10.6%	0.339%
2/1/2023	Bank of Montreal Can	98,600	$0.14M	0.0%	N/A	0.221%
1/12/2023	Assenagon Asset Management S.A.	179,543	$0.25M	0.0%	+7.8%	0.402%
11/8/2022	Atom Investors LP	18,298	$28K	0.0%	-45.9%	0.041%
11/7/2022	Virtu Financial LLC	34,311	$53K	0.0%	+173.1%	0.079%
11/3/2022	Creative Planning	25,575	$39K	0.0%	N/A	0.059%
10/27/2022	Assenagon Asset Management S.A.	166,534	$0.26M	0.0%	+7.3%	0.385%
8/15/2022	Laurion Capital Management LP	722,100	$1.59M	0.0%	N/A	1.667%
8/1/2022	Chartwell Investment Partners LLC	296,507	$0.65M	0.0%	+266.1%	0.685%
7/27/2022	Assenagon Asset Management S.A.	155,190	$0.34M	0.0%	-52.2%	0.358%
5/17/2022	Eventide Asset Management LLC	1,467,922	$3.64M	0.1%	-12.1%	3.389%
5/11/2022	ACT Capital Management LLC	120,600	$0.30M	0.3%	+17.7%	0.278%
5/11/2022	GSA Capital Partners LLP	63,749	$0.16M	0.0%	+311.0%	0.147%
5/10/2022	Mercer Global Advisors Inc. ADV	147,857	$0.37M	0.0%	-21.5%	0.341%
4/25/2022	Assenagon Asset Management S.A.	324,460	$0.81M	0.0%	N/A	0.749%
2/15/2022	Chartwell Investment Partners LLC	77,607	$0.47M	0.0%	N/A	0.196%
2/15/2022	Kennedy Capital Management Inc.	170,447	$1.02M	0.0%	-3.1%	0.431%
2/14/2022	Altium Capital Management LP	337,000	$2.03M	0.6%	-3.4%	0.852%
2/14/2022	Point72 Asset Management L.P.	501,649	$3.02M	0.0%	N/A	1.268%
2/14/2022	Blair William & Co. IL	207,490	$1.25M	0.0%	-1.6%	0.525%
2/14/2022	GSA Capital Partners LLP	15,512	$93K	0.0%	N/A	0.039%
2/14/2022	Elkhorn Partners Limited Partnership	17,300	$0.10M	0.1%	+28.1%	0.044%
2/9/2022	Principal Financial Group Inc.	80,307	$0.48M	0.0%	-45.5%	0.203%
2/8/2022	Northern Trust Corp	339,081	$2.04M	0.0%	+4.7%	0.857%
2/7/2022	SG Americas Securities LLC	36,292	$0.22M	0.0%	-30.6%	0.092%
2/4/2022	Mercer Global Advisors Inc. ADV	188,357	$1.13M	0.0%	+8.7%	0.476%
11/17/2021	Altium Capital Management LP	348,888	$2.32M	0.5%	-30.5%	0.882%
11/16/2021	Janus Henderson Group PLC	3,533,381	$23.54M	0.0%	+12.1%	8.934%
11/16/2021	Two Sigma Advisers LP	700,800	$4.67M	0.0%	+5.4%	1.772%
11/16/2021	Two Sigma Investments LP	604,750	$4.03M	0.0%	-14.7%	1.529%
11/16/2021	Metropolitan Life Insurance Co NY	11,065	$74K	0.0%	N/A	0.028%
11/16/2021	Caxton Corp	2,522,083	$16.80M	13.6%	+7.6%	6.377%
11/15/2021	Marshall Wace LLP	18,769	$0.13M	0.0%	-92.6%	0.047%
11/15/2021	HighVista Strategies LLC	15,501	$0.10M	0.1%	N/A	0.039%
11/12/2021	The Manufacturers Life Insurance Company	24,853	$0.17M	0.0%	+10.4%	0.063%
11/12/2021	Geode Capital Management LLC	582,157	$3.88M	0.0%	+13.0%	1.472%
11/10/2021	Mercer Global Advisors Inc. ADV	173,357	$1.16M	0.0%	+3.3%	0.438%
11/10/2021	Goldman Sachs Group Inc.	357,672	$2.38M	0.0%	+333.4%	0.904%
11/9/2021	BlackRock Inc.	2,387,748	$15.90M	0.0%	+1.2%	6.037%
11/9/2021	Principal Financial Group Inc.	147,341	$0.98M	0.0%	-1.5%	0.373%
11/8/2021	State Board of Administration of Florida Retirement System	30,142	$0.20M	0.0%	+182.4%	0.076%
11/4/2021	Tortoise Investment Management LLC	15,000	$100K	0.0%	-25.0%	0.038%
11/4/2021	Deutsche Bank AG	245,964	$1.64M	0.0%	-23.5%	0.622%
11/2/2021	New York State Common Retirement Fund	15,868	$0.11M	0.0%	-48.6%	0.040%
11/1/2021	SG Americas Securities LLC	52,258	$0.35M	0.0%	N/A	0.132%
10/28/2021	WINTON GROUP Ltd	43,865	$0.29M	0.0%	+86.8%	0.111%
10/18/2021	Nisa Investment Advisors LLC	7,000	$47K	0.0%	N/A	0.018%
9/17/2021	Virtu Financial LLC	19,925	$0.13M	0.0%	-40.1%	0.050%
8/25/2021	Marshall Wace LLP	254,929	$1.70M	0.0%	N/A	0.645%
8/17/2021	Octagon Capital Advisors LP	982,753	$6.54M	1.4%	+51.2%	2.485%
8/17/2021	Caxton Corp	2,343,333	$15.58M	10.7%	+10.8%	5.925%
8/16/2021	Cubist Systematic Strategies LLC	47,344	$0.32M	0.0%	-48.6%	0.120%
8/16/2021	Opaleye Management Inc.	463,000	$3.08M	0.5%	-19.6%	1.171%
8/16/2021	California State Teachers Retirement System	49,946	$0.33M	0.0%	N/A	0.126%
8/16/2021	Morgan Stanley	467,461	$3.11M	0.0%	+1,741.2%	1.182%
8/16/2021	Kennedy Capital Management Inc.	265,128	$1.76M	0.0%	-1.2%	0.670%
8/16/2021	Charles Schwab Investment Management Inc.	85,617	$0.57M	0.0%	N/A	0.216%
8/16/2021	State Street Corp	494,491	$3.29M	0.0%	+4,413.4%	1.250%
8/16/2021	Nuveen Asset Management LLC	194,241	$1.29M	0.0%	N/A	0.491%

Data available starting January 2016

Cardiff Oncology, Inc., a clinical-stage biotechnology company, develops novel therapies to treat various cancers in California. Its lead drug candidate is onvansertib, an oral selective Polo-like Kinase 1 Inhibitor to treatment a range of solid tumor cancers and KRAS/NRAS-mutated metastatic colorectal and metastatic pancreatic cancer, as well as investigator-initiated trials in triple negative breast cancer and small cell lung cancer; and TROV-054 is a Phase 1b/2 for FOLFIRI and bevacizumab. The company primarily serves pharmaceutical manufacturers. The company was formerly known as Trovagene, Inc. and changed its name to Cardiff Oncology, Inc. in May 2012. Cardiff Oncology, Inc. was incorporated in 1999 and is headquartered in San Diego, California.

Today's Range

Now: $2.50

$2.46

$2.59

50 Day Range

MA: $2.84

$2.46

$4.09

52 Week Range

Now: $2.50

$1.13

$6.42

Volume

476,890 shs

Average Volume

945,633 shs

Market Capitalization

$127.83 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.93

Who are the company insiders with the largest holdings of Cardiff Oncology?: Cardiff Oncology's top insider shareholders include:
Gary W Pace (Director)
Mark Erlander (CEO)
Learn More about top insider investors at Cardiff Oncology.
Who are the major institutional investors of Cardiff Oncology?: Cardiff Oncology's top institutional shareholders include:
Geode Capital Management LLC — 1.82%
State Street Corp — 1.63%
MAI Capital Management — 1.43%
Assenagon Asset Management S.A. — 0.60%
GSA Capital Partners LLP — 0.40%
Charles Schwab Investment Management Inc. — 0.26%
Learn More about top institutional investors of Cardiff Oncology stock.
Which major investors are selling Cardiff Oncology stock?: In the last quarter, CRDF stock was sold by these institutional investors:
Assenagon Asset Management S.A.
Jane Street Group LLC
Invst LLC
Which major investors are buying Cardiff Oncology stock?: During the previous quarter, CRDF stock was acquired by institutional investors including:
GSA Capital Partners LLP
Barclays PLC
Barclays PLC
XTX Topco Ltd
State Street Corp
SG Americas Securities LLC
Geode Capital Management LLC
Wolverine Trading LLC
Within the previous year, these company insiders have bought Cardiff Oncology stock:
Gary W Pace (Director)
Mark Erlander (CEO)
Learn More investors buying Cardiff Oncology stock.